Sign up for upcoming conferences in the PROGRAMS section! | Dry Eye Rescue Is Offering Friends Of MDA A 20% Discount On All Products To Help With Your Eye Conditions

Click Here To Save Now

Resources

Mar 7, 2023

MacuHealth & Macular Degeneration Association announce partnership

Press Release  The Macular Degeneration Association and MacuHealth Announce Partnership   BIRMINGHAM, Mich., March 07, 2023 – The Macular Degeneration

MacuHealth & Macular Degeneration Association announce partnership

Mar 7, 2023

Eyedaptic unveils the EYE5 glasses with EyeSwitch™

The latest model in the Eyedaptic product showcase boasts comfort without sacrificing usability and adds brand-new artificial intelligence features. Laguna

Eyedaptic unveils the EYE5 glasses with EyeSwitch™

Feb 28, 2023

February as Low Vision and Age-Related Macular Degeneration (AMD) Awareness Month.

These conditions impact millions (AMD alone affects 196M) of individuals worldwide. This month highlights the importance of those with low vision

February as Low Vision and Age-Related Macular Degeneration (AMD) Awareness Month.

Feb 28, 2023

AFLIBERCEPT 8 MG BLA FOR TREATMENT OF WET AGE-RELATED MACULAR DEGENERATION AND DIABETIC MACULAR EDEMA ACCEPTED FOR FDA PRIORITY REVIEW

Breaking News BLA supported by two pivotal trials demonstrating non-inferior vision gains to EYLEA® (aflibercept) Injection, with vast majority of patients

AFLIBERCEPT 8 MG BLA FOR TREATMENT OF WET AGE-RELATED MACULAR DEGENERATION AND DIABETIC MACULAR EDEMA ACCEPTED FOR FDA PRIORITY REVIEW

Feb 22, 2023

Researchers identify a new genetic risk factor for age-related macular degeneration

Reviewed by Emily Henderson, B.SC. Researchers at Tel Aviv University identified a new genetic risk factor for the complex eye

Researchers identify a new genetic risk factor for age-related macular degeneration

Feb 19, 2023

FDA Approves Apellis’ SYFOVRE™, for the Treatment of Geographic Atrophy Secondary to Age-Related Macular Degeneration (AMD)

Newly approved treatment for Geographic Atrophy by FDA Geographic atrophy (GA) is the advanced form of dry age-related macular degeneration

FDA Approves Apellis’ SYFOVRE™, for the Treatment of Geographic Atrophy Secondary to Age-Related Macular Degeneration (AMD)

Feb 13, 2023

February is AMD Awareness & Low Vision Month

  Here are some helpful tips to help.   1. Speak to your eye care professional to see if there

February is AMD Awareness & Low Vision Month

Feb 13, 2023

AMD-See the Day

New services available at CVS in Tampa, FL Don’t let age dim your vision. As we age, our eyes change,

AMD-See the Day

Feb 9, 2023

FDA grants fast track designation for retinitis pigmentosa treatment

EA-2353 for the treatment of retinitis pigmentosa received fast-track designation from the FDA, according to a press release from Endogena Therapeutics.

FDA grants fast track designation for retinitis pigmentosa treatment

Feb 7, 2023

February is Macular Degeneration & Low Vision Awareness month

Low vision looks different for everyone — literally. These are four examples of what blindness can look like. Blindness is

February is Macular Degeneration & Low Vision Awareness month

Jan 25, 2023

More Than 1 in 4 Americans Over 70 Has Impaired Vision

by: Dennis Thompson Key Takeaways More than a quarter of U.S. seniors is living with an untreated vision problem —

More Than 1 in 4 Americans Over 70 Has Impaired Vision

Jan 17, 2023

Glaucoma Awareness Month

Glaucoma is a leading cause of vision loss and blindness in the United States. Glaucoma has no early symptoms —

Glaucoma Awareness Month

Jan 17, 2023

Clinical Trials & Early Access Program- Apellis

Clinical trials are a critical component of our efforts to deliver innovative therapies to people living with serious diseases, and

Clinical Trials & Early Access Program- Apellis

Jan 17, 2023

Tampa Vision Seminar

Join the Macular Degeneration Association and the Foundation Fighting Blindness, Tampa Chapter at TPepin’s Hospitality Centre. Secure your spot today!

Tampa Vision Seminar

Jan 16, 2023

Health Benefits of Dates: A Sweet Superfood for a Healthy Life

By Happy Sharer Introduction Dates are a popular sweet snack that has been enjoyed around the world for thousands of

Health Benefits of Dates: A Sweet Superfood for a Healthy Life

Jan 10, 2023

False Positive Neovascular AMD Results May Foretell Future Conversion

by: Lauren Dembeck, PhD ForeseeHome false positive alerts in fellow eyes to eyes with neovascular age-related macular degeneration predict future

False Positive Neovascular AMD Results May Foretell Future Conversion

Jan 2, 2023

The Macular Degeneration Association is proud to highlight Medical Board Member, JEREMIAH BROWN, JR., MS, MD

Dr. Jeremiah Brown, Jr. is a board-certified ophthalmologist with more than 10 years of practice experience as a Vitreoretinal Surgeon.

The Macular Degeneration Association is proud to highlight Medical Board Member, JEREMIAH BROWN, JR., MS, MD

Jan 2, 2023

Late-Stage AMD Patients Needed: Study Underway to Evaluate a New-Generation Implantable Miniature Telescope

In 2010, the U.S. Food and Drug Administration (FDA) approved a novel device from Samsara Vision called the Implantable Miniature

Late-Stage AMD Patients Needed: Study Underway to Evaluate a New-Generation Implantable Miniature Telescope

Jan 1, 2023

Happy New Year 2023

The Macular Degeneration Association wanted to wish everyone a very Happy 2023.

Happy New Year 2023

Dec 27, 2022

More Than an Eye Exam: How Nutrition and Lifestyle Can Improve Eye Health

We have all heard the saying, “You are what you eat,” and nutrition gives us the power to choose our

More Than an Eye Exam: How Nutrition and Lifestyle Can Improve Eye Health

Dec 23, 2022

Retina Specialist and Optometrist Comanagement of AMD Patients

Eye care professionals can partner for optimal patient care. By Jeffry Gerson, OD; Rishi P. Singh, MD Although age-related macular degeneration (AMD)

Retina Specialist and Optometrist Comanagement of AMD Patients

Dec 19, 2022

My Accessible Kitchen Tour

In this video, I take a tour through my kitchen and show all the gadgets and tricks I use.  

My Accessible Kitchen Tour

Dec 14, 2022

AmazonSmile

You can help support the Macular Degeneration Association at no additional cost. Simply add us to your charity choice on

AmazonSmile

Dec 14, 2022

New potential mechanism for vision loss discovered

New research is being conducted but is not ready for release yet. by: David Hutton Researchers from the Deutsches Zentrum

New potential mechanism for vision loss discovered

Dec 5, 2022

Putting stem cell-based therapies in context

Karen M. Wai, M.D., Theodore Leng, M.D., MS, and Jeffrey Goldberg, M.D., Ph.D., Byers Eye Institute at Stanford, Stanford University

Putting stem cell-based therapies in context

Nov 30, 2022

Matters of Vision! 2022 Last 2 meetings

EXCITING NEWS about dry macular degeneration is being presented at the Matters of Vision! 2022 last 2 meetings. 12.03.22 Atlanta,

Matters of Vision! 2022 Last 2 meetings

Nov 26, 2022

Happy Thanksgiving

The Macular Degeneration Association wanted to wish you and your family a happy and wonderful Thanksgiving. We appreciate and are

Happy Thanksgiving

Nov 26, 2022

The Surprising Effects of Smoking and How You Can Finally Quit the Habit

By The West News t’s common knowledge that smoking is bad for your health. In fact, our article ‘The Eight Most Major

The Surprising Effects of Smoking and How You Can Finally Quit the Habit

Nov 19, 2022

New Stem Cell Treatment Developed for AMD

RESTORING LOST VISION BY AMBER SNYDER Dr. Kapil Bharti of NEI is developing a stem cell-based therapy to prevent and restore

New Stem Cell Treatment Developed for AMD

Nov 18, 2022

The consequences of Geographic Atrophy (GA)

The consequences of Geographic Atrophy (GA) are too critical to be ignored.1-3 Even when visual acuity is relatively unchanged in

The consequences of Geographic Atrophy (GA)

Newsletter Sign-up

  • This field is for validation purposes and should be left unchanged.